Red Light Holland, Creso Pharma Walk From Merger Due To COVID Headwinds

Red Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH) evidently have elected to walk from their previously announced merger arrangement. The termination is being blamed largely on the impacts of the ongoing COVID-19 pandemic.

“Unfortunately, the geographic span of our respective businesses made a merger at this time impractical,” commented Creso’s Chairman Alex Blumenthal.

Among other items related to the previously proposed merger, significant global travel restrictions were identified as a major headwind to bringing the two firms together, with both firms featuring sprawling global operations. The limitations were expected to make integration difficult across all business units, thereby heavily limiting the previously anticipated synergies that the merger would bring.

Despite the merger being mutually terminated, it appears that not all has been lost. The two firms will continue to work together on a go-forward basis, with Creso seeing its products white-labelled by Red Light and distributed across the firms current wholesale channels.

Red Light Holland commented that it will continue to look for M&A opportunities within North America, and that Bruce Linton will remain as Chairman of the firms Advisory Board.

Red Light Holland last traded at $0.26 on the CSE.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Creso Pharma Sees Canadian Subsidiary Secure Numerous Purchase Orders

Creso Pharma (ASX: CPH) this morning announced that it has secured a number of new...

Thursday, February 4, 2021, 07:03:33 AM

Mernova: Creso Pharm’s Licensed Cannabis Producer – The Daily Dive feat Jack Yu

Today on the Daily Dive, we sit down with Jack Yu, managing director of Mernova...

Thursday, February 11, 2021, 01:30:00 PM

Creso Pharma Positions Itself For Changing Australian CBD Regulations

Creso Pharma (ASX: CPH) this morning welcomed the advent of changing Australian laws as they...

Monday, February 1, 2021, 07:20:34 AM

Red Light Holland Grows Cash Position To $12.2 Million With Warrant Exercises

Red Light Holland (CSE: TRIP) is evidently cashed up as a result of the recent...

Thursday, December 24, 2020, 08:47:45 AM

Creso’s Canadian Subsidiary Sees $494,000 In Additional Orders

Creso Pharma (ASX: CPH) this morning announced that its Canadian subsidiary, Mernova Medicinal, has obtained...

Wednesday, February 17, 2021, 10:16:02 AM